Revolution Medicines, Inc. (RVMDW) — 8-K Filings

8-K Filings (12)

• Revolution Medicines Files 8-K — Oct 17, 2025 Risk: low
  On October 16, 2025, Revolution Medicines, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific financia
• Revolution Medicines Files 8-K — Sep 10, 2025 Risk: low
  On September 10, 2025, Revolution Medicines, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific financ
• Revolution Medicines Files 8-K on Shareholder Matters — Jun 27, 2025 Risk: low
  Revolution Medicines, Inc. filed an 8-K on June 27, 2025, reporting on matters submitted to a vote of security holders as of June 26, 2025. The filing details t
• Revolution Medicines Enters Material Definitive Agreement — Jun 24, 2025 Risk: medium
  On June 23, 2025, Revolution Medicines, Inc. entered into a material definitive agreement. This filing also indicates the creation of a direct financial obligat
• Revolution Medicines Reports Board and Executive Changes — Jun 18, 2025 Risk: medium
  Revolution Medicines, Inc. announced on June 18, 2025, changes related to its board of directors and executive compensation. Specifically, the company reported
• Revolution Medicines Files 8-K — Dec 5, 2024 Risk: low
  Revolution Medicines, Inc. filed an 8-K on December 5, 2024, reporting other events and financial statements/exhibits as of December 3, 2024. The company, incor
• Revolution Medicines Files 8-K: Other Events — Dec 2, 2024 Risk: medium
  On December 2, 2024, Revolution Medicines, Inc. filed an 8-K report. The filing indicates an "Other Events" item, suggesting a significant development not cover
• Revolution Medicines Files 8-K Report — Oct 25, 2024 Risk: low
  On October 25, 2024, Revolution Medicines, Inc. filed an 8-K report. The filing pertains to 'Other Events' and does not disclose specific financial transactions
• Revolution Medicines Files 8-K — Oct 23, 2024 Risk: low
  On October 23, 2024, Revolution Medicines, Inc. filed an 8-K report. The filing indicates that the company is providing information under "Other Events" and is
• Revolution Medicines Raises $400M from Stock and Warrant Offerings — Jul 15, 2024 Risk: medium
  On July 15, 2024, Revolution Medicines, Inc. filed an 8-K report detailing several events. The company announced the closing of its previously disclosed underwr
• Revolution Medicines Reports Shareholder Vote Matters — Jun 24, 2024 Risk: low
  Revolution Medicines, Inc. filed an 8-K on June 24, 2024, reporting on matters submitted to a vote of security holders on June 20, 2024. The filing details acti
• Revolution Medicines Files 8-K on Financials & Reg FD Disclosure — Jan 9, 2024
  Revolution Medicines, Inc. filed an 8-K on January 9, 2024, to disclose information under Item 2.02 (Results of Operations and Financial Condition) and Item 7.0

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX